Search research articles
Contact Us
Filters
Showing results (441-450 of 540) with videos related to
Page
of 54
Sort By:
Infectious Diseases and Therapy
|
January 11, 2023
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA
Mindy M Cheng, Carolina Reyes, Sacha Satram, et al.
Free Radical Biology & Medicine
|
February 22, 2025
Exosomes inhibit ferroptosis to alleviate intervertebral disc degeneration via the p62-KEAP1-NRF2 pathway
Chao Chen, Xuenan Wang, Yueqin Zhao, et al.
World Journal of Gastroenterology
|
August 1, 2015
Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status
Yu-Zhen Zheng, Wei Zhao, Yi Hu, et al.
Journal of Medicinal Chemistry
|
December 1, 2025
Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors
Hongfu Lu, Sujing Shi, Huaxing Yu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 3, 2021
Absorption, metabolism and excretion of pictilisib, a potent pan-class I phosphatidylinositol-3-Kinase (PI3K) inhibitor, in rats, dogs, and humans
Qin Yue, S Cyrus Khojasteh, Sungjoon Cho, et al.
The AAPS Journal
|
October 3, 2014
The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria
Marc R Yago, Adam Frymoyer, Leslie Z Benet, et al.
Molecular and Cellular Biology
|
March 18, 2009
Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice
William S Chen, Xiao-Ding Peng, Yong Wang, et al.
Journal of Medicinal Chemistry
|
November 12, 2025
Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB Inhibitors
Fanye Meng, Zhongying Cao, Jinxin Liu, et al.
Frontiers in Oncology
|
May 26, 2022
30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease
Yan Li, Meng Qin, Ying Shan, et al.
European Journal of Medicinal Chemistry
|
February 25, 2020
Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors
Wei Ai, Jian Zhang, Waleed A Zalloum, et al.
Page
of 54
Search research articles
Search
Showing results (441-450 of 540) with videos related to
Sort By:
Page
of 54
Infectious Diseases and Therapy
|
January 11, 2023
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA
Mindy M Cheng, Carolina Reyes, Sacha Satram, et al.
Free Radical Biology & Medicine
|
February 22, 2025
Exosomes inhibit ferroptosis to alleviate intervertebral disc degeneration via the p62-KEAP1-NRF2 pathway
Chao Chen, Xuenan Wang, Yueqin Zhao, et al.
World Journal of Gastroenterology
|
August 1, 2015
Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status
Yu-Zhen Zheng, Wei Zhao, Yi Hu, et al.
Journal of Medicinal Chemistry
|
December 1, 2025
Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors
Hongfu Lu, Sujing Shi, Huaxing Yu, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 3, 2021
Absorption, metabolism and excretion of pictilisib, a potent pan-class I phosphatidylinositol-3-Kinase (PI3K) inhibitor, in rats, dogs, and humans
Qin Yue, S Cyrus Khojasteh, Sungjoon Cho, et al.
The AAPS Journal
|
October 3, 2014
The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria
Marc R Yago, Adam Frymoyer, Leslie Z Benet, et al.
Molecular and Cellular Biology
|
March 18, 2009
Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice
William S Chen, Xiao-Ding Peng, Yong Wang, et al.
Journal of Medicinal Chemistry
|
November 12, 2025
Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB Inhibitors
Fanye Meng, Zhongying Cao, Jinxin Liu, et al.
Frontiers in Oncology
|
May 26, 2022
30-Year Experience With 22 Cases of Malignant Transformation Arising From Ovarian Mature Cystic Teratoma: A Rare Disease
Yan Li, Meng Qin, Ying Shan, et al.
European Journal of Medicinal Chemistry
|
February 25, 2020
Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors
Wei Ai, Jian Zhang, Waleed A Zalloum, et al.
Page
of 54